Compare · ECOR vs ITGR
ECOR vs ITGR
Side-by-side comparison of electroCore Inc. (ECOR) and Integer Holdings Corporation (ITGR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ECOR and ITGR operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- ITGR is the larger of the two at $4.31B, about 57.2x ECOR ($75.3M).
- Over the past year, ECOR is up 62.7% and ITGR is up 20.8% - ECOR leads by 41.9 points.
- ITGR has been more active in the news (6 items in the past 4 weeks vs 1 for ECOR).
- ITGR has more recent analyst coverage (23 ratings vs 2 for ECOR).
- Company
- electroCore Inc.
- Integer Holdings Corporation
- Price
- -
- -
- Market cap
- $75.3M
- $4.31B
- 1M return
- -29.51%
- +0.32%
- 1Y return
- +62.73%
- +20.80%
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NASDAQ
- NYSE
- IPO
- 2018
- News (4w)
- 1
- 6
- Recent ratings
- 2
- 23
electroCore Inc.
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Rockaway, New Jersey.
Integer Holdings Corporation
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Latest ECOR
- Director Errico Thomas J. bought $49,082 worth of shares (5,000 units at $9.82), increasing direct ownership by 1% to 363,904 units (SEC Form 4)
- Amendment: Officer Fox Michael bought $49,004 worth of shares (5,000 units at $9.80), increasing direct ownership by 4% to 130,000 units (SEC Form 4)
- Officer Fox Michael was granted 5,000 shares, increasing direct ownership by 4% to 130,000 units (SEC Form 4)
- Director Theofilos James Charles was granted 11,123 shares, increasing direct ownership by 47% to 34,670 units (SEC Form 4)
- Director Goldstein Julie Ann was granted 11,123 shares, increasing direct ownership by 11% to 112,510 units (SEC Form 4)
- Director Wilber Patricia was granted 11,123 shares, increasing direct ownership by 15% to 83,448 units (SEC Form 4)
- Director Errico Thomas J. was granted 15,572 shares, increasing direct ownership by 5% to 358,904 units (SEC Form 4)
- Director Bonfiglioli Elena was granted 11,123 shares, increasing direct ownership by 36% to 41,672 units (SEC Form 4)
- Officer Fox Michael was granted 55,000 shares, increasing direct ownership by 79% to 125,000 units (SEC Form 4)
- Officer Lev Joshua S. was granted 55,000 shares, increasing direct ownership by 65% to 139,889 units (SEC Form 4)
Latest ITGR
- SEC Form 3 filed by Integer Holdings Corporation
- SEC Form 8-K filed by Integer Holdings Corporation
- Integer Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
- Integer Holdings Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Integer Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR
- Chief Human Resources Officer Thor Kirk K sold $3,981,726 worth of shares (31,540 units at $126.24), decreasing direct ownership by 82% to 7,153 units (SEC Form 4)
- SEC Form DEFM14A filed by Integer Holdings Corporation
- President, Growth & Innovation Senn Andrew sold $1,188,230 worth of shares (9,408 units at $126.30), decreasing direct ownership by 64% to 5,405 units (SEC Form 4)
- SEC Form PREM14A filed by Integer Holdings Corporation